Bryan Clayton is a seasoned global commercial leader with experience across multiple functions including sales and marketing, operations, and software product design. For over 20 years, he has effectively managed cross-functional teams, created new technology solutions, managed contract negotiations, and driven revenue growth for top life sciences technology and solutions providers. Bryan is a sought-after speaker, writer and contributor to industry events and publications, and possesses a range of skills well-suited to boost commercial success and revenue growth.
Bryan joined endpoint Clinical in 2023 as Chief Commercial Officer to lead commercial strategy and business development operations, and to further strengthen endpoint’s expertise in providing agile, patient centric IRT solutions. In his spare time, Bryan coaching and playing baseball.
Phil is the CEO and co-founder of Glasgow based D-CAT, which assists businesses worldwide to meet sustainability and climate change compliance challenges by providing digital monitoring, reporting and verification data services derived from satellite remote sensing data. Phil has over thirty years’ leadership experience across aerospace, defence, and high technology industries. Prior to co-founding D-CAT, Phil held senior leadership positions at Accenture and QinetiQ. The first half of his career was in the Royal Air Force where he served in several operational and MOD staff roles specialising in ground to air missile systems, radar, air defence command and control and the UK MOD’s Digitisation Strategy. He is a Chartered Engineer and Fellow of the Institution of Engineering and Technology.
James joined Auto Trader in 2018, with over 13 years of experience in the automotive industry. In his current role, he is responsible for Auto Trader’s relationships with Captive and Independent lenders, Lease Co’s and Rental Firms, supporting integrate finance API services and delivering value through the use of detailed vehicle data, supporting EV risk management and valuations. Additionally, James leads Auto Trader’s relationships with energy, EV infrastructure and EV battery data firms to support EV adoption. Since joining Auto Trader James has also been a champion of Auto Trader’s environmental agenda, supporting the deployment of the Carbon Literacy Automotive Toolkit to many partners across the UK and internationally. Prior to joining Auto Trader, James worked at Nissan where he was head of Network Development & Strategy in the UK alongside various sales and marketing roles. James holds a BA (Hons) from the University of Kent in Business and Law.
Tanmay is a Senior Director at Medidata Acorn AI. He has 10+ years of experience advising Biopharmas and Biotechs on data and analytics across R&D, medical affairs, and commercial functions. He is passionate about getting life-saving and innovative medicines to patients faster by running more efficient clinical trials. At Medidata, Tanmay co-leads clinical data and analytics solutions and focuses on using Medidata’s database of past clinical trials to solve complex problems in clinical development. Prior to joining Medidata Acorn AI, Tanmay was a management consultant at McKinsey and Company where he co-led the advanced analytics practice in North America.
Rob Emmons covering the Northeast, Mid Atlantic region of the United States with over 23 years experience, works closely with controlled environment customers to provide standard and custom cleaning solutions.
Brigit Wilcox, with Micronova for 14 years, in the industry for 22 years, works closely with controlled environment customers, specializes in identifying tools that increase efficiency with safety a prime consideration.
Zobair M. Younossi is the President of Inova Medicine as well as Professor and Chairman of the Department of Medicine at Inova Fairfax Medical Campus, Falls Church, Virginia, USA. Dr. Younossi earned his medical degree from the University of Rochester School of Medicine and Dentistry (Alpha Omega Alpha 1989) in Rochester, NY, USA. He then completed his residency in internal medicine with a fellowship in gastroenterology and hepatology at Scripps Clinic and Research Foundation in La Jolla, California, USA, while earning his master of public health degree with multiple honours from San Diego State University School of Public Health, San Diego, California, USA.
He served as Staff Hepatologist and Senior Researcher at the Cleveland Clinic Foundation, Cleveland, Ohio, USA, before establishing the Canter for Liver Diseases at Inova Fairfax Hospital, which is now renowned for research related to outcomes research in liver disease and clinical, health services and translational research in non-alcoholic fatty liver disease (NAFLD). He has served as Vice President and Chairman of Research for Inova Health System. He also serves as the President and Chairman of the
Board of Trustees of the Chronic Liver Disease Foundation (2018-Present) and the Board of Inova Health System Foundation (2011-Present). He was appointed by Governors T. Kaine and B. McDonnell of Virginia to the Board of Directors of the Virginia Biotechnology Research Partnership Authority (2008-2014). He also served the Virginia Tobacco & Health Research Repository (VTHRR), Board of Directors, American Heart Association, Mid-Atlantic Affiliate (2010-2012) and Board of the American College of Gastroenterology Institute for Clinical Research & Education (2013-2019). Finally, he has served on
